Lisa White
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisa White has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bonnie J. LaFleur
The University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA
2 shared publications - Andrew P. South
Department of Dermatology University of Wisconsin Carbone Cancer Center, Wisconsin Institute of Medical Research, University of Wisconsin‐Madison Madison Wisconsin USA
1 shared publication Bonnie J. Lafleur
BIO5 Institute, University of Arizona, Tucson, AZ, USA; Department of Pharmacy Practice and Science, University of Arizona, Tucson, AZ, USA
1 shared publication- Clara Curiel-Lewandrowski
The University of Arizona Cancer Center, The University of Arizona, Tucson, Arizona, USA
1 shared publication - Deepta Bhattacharya
Department of Immunobiology, University of Arizona College of Medicine, Tucson, AZ 85724, USA; BIO5 Institute, University of Arizona, Tucson, AZ 85724, USA; Department of Surgery, University of Arizona College of Medicine, Tucson, AZ 85724, USA
1 shared publication - Dimitrios Filioglou
Department of Pediatrics, The University of Arizona College of Medicine Tucson, Tucson, Arizona, USA
1 shared publication
Latest Publications
- Open Access
- 8 September 2025
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (12) , 1037.e1-1037.e14
Haploidentical Versus Matched Sibling Donor HCT in Racially Diverse Pediatric and AYA Patients with Hematologic Malignancies: A Single-Center Comparison
- 8 September 2025
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 31 (12) , 1037.e1-1037.e14
Open AccessHaploidentical Versus Matched Sibling Donor HCT in Racially Diverse Pediatric and AYA Patients with Hematologic Malignancies: A Single-Center Comparison
- Open Access
- 1 December 2023
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 7 (12) , 834-841
No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses
Uptake of mRNA vaccines, especially booster immunizations, against COVID-19 has been lower than hoped, perhaps in part due to their reactogenicity. Analgesics might alleviate symptoms associated with vaccination, but they might also impact immune responses. We semiquantitatively measured Ab responses following COVID-19 vaccination in 2354 human participants surveyed about analgesic use after vaccination. Participants who used nonsteroidal anti-inflammatory drugs or acetaminophen after vaccination showed elevated Ab levels against the receptor-binding domain of Spike protein relative to those who did not use analgesics. This pattern was observed for both mRNA-1273 and BNT162b2 and across age groups. Participants who used analgesics more frequently reported fatigue, muscle aches, and headaches than did those who did not use painkillers. Among participants who reported these symptoms, we observed no statistically significant differences in Ab levels irrespective of analgesic use. These data suggest that elevated Ab levels are associated with symptoms and inflammatory processes rather than painkiller use per se. Taken together, we find no evidence that analgesic use reduces Ab responses after COVID-19 vaccination. Recommendation of their use to alleviate symptoms might improve uptake of booster immunizations.
- 1 December 2023
- Published by Oxford University Press (OUP) in ImmunoHorizons
- Vol. 7 (12) , 834-841
Open AccessNo Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses
Uptake of mRNA vaccines, especially booster immunizations, against COVID-19 has been lower than hoped, perhaps in part due to their reactogenicity. Analgesics might alleviate symptoms associated with vaccination, but they might also impact immune responses. We semiquantitatively measured Ab responses following COVID-19 vaccination in 2354 human participants surveyed about analgesic use after vaccination. Participants who used nonsteroidal anti-inflammatory drugs or acetaminophen after vaccination showed elevated Ab levels against the receptor-binding domain of Spike protein relative to those who did not use analgesics. This pattern was observed for both mRNA-1273 and BNT162b2 and across age groups. Participants who used analgesics more frequently reported fatigue, muscle aches, and headaches than did those who did not use painkillers. Among participants who reported these symptoms, we observed no statistically significant differences in Ab levels irrespective of analgesic use. These data suggest that elevated Ab levels are associated with symptoms and inflammatory processes rather than painkiller use per se. Taken together, we find no evidence that analgesic use reduces Ab responses after COVID-19 vaccination. Recommendation of their use to alleviate symptoms might improve uptake of booster immunizations.
- Open Access
- 26 January 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (7) , 1299-1302.e3
Characterizing Dermal Transcriptional Change in the Progression from Sun-Protected Skin to Actinic Keratosis
- 26 January 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (7) , 1299-1302.e3
Open AccessCharacterizing Dermal Transcriptional Change in the Progression from Sun-Protected Skin to Actinic Keratosis